预填充生物药物输送系统市场 (-2028)

特种预填充注射器，包括笔和自动注射器，正在为药物开发商和市场参与者创造新的机会。 这些设备提供了在直接面向消费者的销售时代区分产品的能力。

本报告考察了全球可预填充生物药物输送系统市场，并提供了市场概况，包括按细分市场划分的产品概况、监管趋势以及进入该市场的公司概况。

内容

执行摘要

生物製剂的传播

• 治疗性单克隆抗体
• 治疗需求的驱动因素
• 竞争格局
• 风险因素
• 用于生物製品的可预填充商业设备
• 手动注射自动注射器
• 自动注射自动注射器
• 一次性自动注射器

汽车注射器产品概述

• Molly
• Molly RNS
• Bertha
• Maggie
• Amber
• SafeLock
• VSDI +NIT
• SDI MIX +NIT
• Syrina Platform
• Syrina S
• Syrina AS
• AutoJect 2
• SelfDose
• Flexi-Q PFS
• OTS Autoinjector
• Consort Medical ASI
• Ypsomed VarioJect
• Rotaject Technology
• Viscala Autoinjector
• Flexi-Q HV
• Intevia

无线自动注射器

• BETACONNECT
• DataPen
• OneJet
• Alubena
• Flexi-Q eMU
• RebiSmart
• 特定于产品的预填充自动注射器
• Alsuma/Sumatriptan Autoinjector
• Sumatriptan
• Rebif/Rebidose
• Aimovig
• Enbrel Mini AutoTouch
• Pegasys Proclick
• Rasuvo
• Otrexup
• Evzio

设备设计因素

• 材料选择问题
• 零件数量和设备成本
• 安全功能
• 进针深度
• 故障保护激活
• 剂量检查/注射确认
• 冻干药物/重构
• 人体工程学/人体工程学

笔式註射器

• 标准化笔平台
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Ypsomed
• SHL Medical
• 定製笔设计
• 可重复使用的笔
• 双腔笔

商业钢笔产品

• 促性腺激素笔
• Humatropen/Humatropen 3
• Hematropen 产品概览
• 去甲肾上腺素
• Neutropin AQ 笔
• Neutropin AQ Pen 概述
• Omnitrope
• Omnitrope Pen 产品概述
• one.click
• one.click 笔产品概述
• 副甲状腺激素
• Forteo Pen
• Preotact/Preos
• Natpara

生殖激素

• 专业笔类产品
• Follistim/Puregon 笔
• Follistim Pen 产品概览
• Gonal-f
• Gonal-f Rediject 笔产品概述
• 可穿戴设备
• 贴片泵
• 很多可穿戴设备
• 可穿戴产品分析
• Libertas
• 贴片泵
• SmartDose
• Neulasta OnPro Injector
• YpsoDose

电子半一次性

• E3D 贴片泵
• 一次性机械
• enFuse
• 俘虏设备
• sc2Wear Infuso
• 贴片泵
• 新兴技术
• 无线数据

重点治疗领域分析

• 过敏反应和对策
• 自身免疫性疾病
• 类风湿性关节炎
• 银屑病
• 多发性硬化症
• 艾塞那□
• 布道龙
• 普尼□
• 阿布鲁□
• 紧急护理
• 肝炎
• 造血
• 荷尔蒙
• 骨质疏鬆症

市场因素

• 监管问题
• 设备品牌
• 患者依从性和可用性
• 医疗经济学
• 公司简介

“Prefillable Biological Drug Delivery Systems to 2028 ” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this growing segment of the drug delivery sector. The report has been designed and developed to provide pharmaceutical company decision makers, drug developers and formulators, drug device designers, and industry strategists with a detailed understanding of the expanding impact of biological drug self-care on pharmaceutical strategies and healthcare treatment protocols. Provider organization business managers, healthcare administrators and investors will also benefit from this publication.

Device Evolution and the Growth of Self-care Biologics

Specialty prefilled injection devices - a group that includes pen injectors and autoinjectors - are creating new opportunities for drug developers and marketers. These devices provide the ability to create product differentiation in the age of direct-to-consumer marketing.

Because biological drugs most often target chronic conditions, dosing strategies and treatment protocols must be developed for long-term use, often for self-administration by patients who may have limitations directly related to their condition. The shift in as-supplied packaging from single and multi-use vials to prefilled injection devices will accelerate over the next five years as drug developers move to empower an increasing number of chronically ill patients. The powerful physiological effects of antibodies, hormones and other biological drugs also increase the need for safety and compliance.

What You Will Learn:

• What are the market factors driving commercial activity in the biologicals drug delivery segment?

• What are the major factors driving as-supplied product development decisions within biological drug development organizations?

• How does the availability of patient support resources influence the prescribing decision for biological drugs?

• How important are drug developer-formulation technologist relationships in the biological drug packaging segment?

• What are the key influencers regarding as-supplied packaging in the biological self-administration market segment?

• What are the significant economic, technology, and regulatory factors affecting the selection criteria for self-administered biological drugs?

Table of Contents

Executive Summary

• Prefillable Biological Drug Delivery Systems
• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs

Proliferation of Biological Drugs

• Therapeutic Monoclonal Antibodies
• Therapeutic Demand Drivers
• Competitive Landscape
• Risk Factors
• Prefillable Commercial Devices for Biologicals
• Manual Injection Autoinjectors
• Automated Injection Autoinjectors
• Disposable Autoinjectors

Autoinjector Product Summaries

• Molly
• Molly RNS
• Bertha
• Maggie
• Amber
• SafeLock
• VSDI +NIT
• SDI MIX +NIT
• Syrina Platform
• Syrina S
• Syrina AS
• AutoJect 2
• SelfDose
• Flexi-Q PFS
• OTS Autoinjector
• Consort Medical ASI
• Ypsomed VarioJect
• Rotaject Technology
• Viscala Autoinjector
• Flexi-Q HV
• Intevia

Wirelessly Enabled Autoinjectors

• BETACONNECT
• DataPen
• OneJet
• Alubena
• Flexi-Q eMU
• RebiSmart
• Selected Product Specific Prefillable Autoinjectors
• Alsuma/Sumatriptan Autoinjector
• Sumatriptan
• Rebif/Rebidose
• Aimovig
• Enbrel Mini AutoTouch
• Pegasys Proclick
• Rasuvo
• Otrexup
• Evzio

Device Design Factors

• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation
• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics

Pen Injectors

• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Ypsomed
• SHL Medical
• Custom Pen Designs
• Reusable Pens
• Dual Chamber Pens

Commercial Pen Products

• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Hematro-Pen Product Summary
• Norditropin
• Nutropin AQ Pen
• Nutropin AQ Pen Summary
• Omnitrope
• Omnitrope Pen Product Summary
• One.Click
• one.click Pen Product summary
• Parathyroid Hormones
• Forteo Pen
• Preotact/Preos
• Natpara

Reproductive Hormones

• Commercial Pen Products
• Follistim/Puregon Pen
• Follistim Pen Product Summary
• Gonal-f
• Gonal-f Rediject Pen Product Summary
• Wearable Devices
• Patch Pumps
• Large Volume Wearable Devices
• Wearables Product Analysis
• Libertas
• Patch Pump
• SmartDose
• Neulasta OnPro Injector
• YpsoDose

Electronic Semi-disposable

• E3D Patch Pump
• Mechanical Disposable
• enFuse
• Captive Devices
• sc2Wear Infusor
• PatchPump
• Emerging Technology
• Wireless Data

Key Therapeutic Sector Analysis

• Anaphylaxis/Countermeasures
• Autoimmune Diseases
• Rheumatoid Arthritis
• Psoriasis
• Multiple Sclerosis
• Exenatide
• Bydureon
• Pramlinitide
• Abliglutide
• Emergency Medicine
• Hepatitis
• Hematopoietics
• Hormones
• Osteoporosis

Market Factors

• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics
• Company Profiles